| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $0.5B | $0.7B | $0.6B | $0.5B | $0.4B | $0.5B | $0.5B |
| Net Income | $0.6B | $0.4B | $0.5B | $0.4B | $0.4B | $0.2B | $0.4B | $0.3B |
| EPS (Basic) | $5.78 | $3.54 | $4.86 | $4.32 | $3.83 | $1.08 | $1.02 | $0.97 |
| EPS (Diluted) | $5.77 | $3.52 | $4.85 | $4.31 | $3.83 | $1.08 | $1.02 | $0.96 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B | $6.6B | $6.6B | $6.5B | $6.0B | $5.8B | $5.9B | $4.5B |
| Current Assets | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.4B |
| Cash & Equivalents | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $5.9B | $5.5B | $5.3B | $5.3B | $4.8B | $4.6B | $4.8B | $3.4B |
| Current Liabilities | $0.8B | $0.8B | $0.7B | $0.7B | $0.7B | $0.5B | $0.7B | $0.5B |
| Stockholders' Equity | — | — | — | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.8B | $0.8B | $0.7B | $0.6B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.3B | $-0.6B | $-0.5B | $-0.1B | $-0.4B | $-0.6B |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.6B | $-0.7B | $-0.5B | $-0.2B | $-0.3B | $-0.4B | $-0.3B | $-0.1B |